Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave

Drugmakers Seek Partners To Ease Market Challenges

Novartis, Astellas, AstraZeneca and Gilead are among big pharma firms still seeking next wave technologies (Shutterstock)

More from Scrip

More from Cell Therapies